ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)
Public ClinicalTrials.gov record NCT06342947. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of ALG-055009 in Non-Cirrhotic Adults With Metabolic Dysfunction-Associated Steatohepatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2a study to evaluate the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of oral (PO) daily (QD) doses of ALG-055009 (soft gelatin \[softgel\] capsule) for 12 weeks.
Study identification
- NCT ID
- NCT06342947
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 102 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 1, 2024 (Actual)
- Primary completion
- Aug 19, 2024 (Actual)
- Completion
- Sep 9, 2024 (Actual)
- Last update posted
- Feb 17, 2025
2024
United States locations
- U.S. sites
- 40
- U.S. states
- 16
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aligos Clinical Study Site 18 | Chandler | Arizona | 85224 | — |
| Aligos Clinical Study Site 15 | Peoria | Arizona | 85301 | — |
| Aligos Clinical Study Site 17 | Tucson | Arizona | 85641 | — |
| Aligos Clinical Study Site 35 | Chula Vista | California | 91902 | — |
| Aligos Clinical Study Site 1 | Lincoln | California | 95648 | — |
| Aligos Clinical Study Site 37 | Poway | California | 92025 | — |
| Aligos Clinical Study Site 10 | Rialto | California | 92316 | — |
| Aligos Clinical Study Site 26 | Bradenton | Florida | 34205 | — |
| Aligos Clinical Study Site 25 | Clearwater | Florida | 33755 | — |
| Aligos Clinical Study Site 39 | Fort Myers | Florida | 33901 | — |
| Aligos Clinical Study Site 2 | Maitland | Florida | 32751, 32794 | — |
| Aligos Clinical Study Site 22 | Ocoee | Florida | 32703 | — |
| Aligos Clinical Study Site 32 | Port Orange | Florida | 32119 | — |
| Aligos Clinical Study Site 38 | Sarasota | Florida | 34230 | — |
| Aligos Clinical Study Site 31 | The Villages | Florida | 32159 | — |
| Aligos Clinical Study Site 3 | Viera | Florida | 32924 | — |
| Aligos Clinical Study Site 30 | Winter Park | Florida | 32789 | — |
| Aligos Clinical Study Site 23 | Athens | Georgia | 30601 | — |
| Aligos Clinical Study Site 12 | Topeka | Kansas | 66546 | — |
| Aligos Clinical Study Site 29 | Louisville | Kentucky | 40018 | — |
| Aligos Clinical Study Site 24 | Bastrop | Louisiana | 71220 | — |
| Aligos Clinical Study Site 5 | Houma | Louisiana | 70360 | — |
| Aligos Clinical Study Site 4 | Marrero | Louisiana | 70072 | — |
| Aligos Clinical Study Site 6 | Metairie | Louisiana | 70001 | — |
| Aligos Clinical Study Site 14 | Chesterfield | Michigan | 48047 | — |
| Aligos Clinical Study Site 7 | New York | New York | 10001 | — |
| Aligos Clinical Study Site 8 | Morehead City | North Carolina | 28557 | — |
| Aligos Clinical Study Site 21 | Columbus | Ohio | 43004 | — |
| Aligos Clinical Study Site 16 | Westlake | Ohio | 44145 | — |
| Aligos Clinical Study Site 36 | East Greenwich | Rhode Island | 02818 | — |
| Aligos Clinical Study Site 9 | Nashville | Tennessee | 37011 | — |
| Aligos Clinical Study Site 19 | Austin | Texas | 73301 | — |
| Aligos Clinical Study Site 33 | Bellaire | Texas | 77401 | — |
| Aligos Clinical Study Site 27 | Brownsville | Texas | 78520 | — |
| Aligos Clinical Study Site 28 | Edinburg | Texas | 78504 | — |
| Aligos Clinical Study Site 40 | Farmers Branch | Texas | 75006 | — |
| Aligos Clinical Study Site 20 | San Antonio | Texas | 78015 | — |
| Aligos Clinical Study Site 11 | Waco | Texas | 76633 | — |
| Aligos Clinical Study Site 13 | Manassas | Virginia | 20108 | — |
| Aligos Clinical Study Site 34 | Seattle | Washington | 98039 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06342947, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 17, 2025 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06342947 live on ClinicalTrials.gov.